Jodie Michele Reed

Title: Jodie Michele Reed: Innovator in Inhibiting Trimethylamine Production

Introduction

Jodie Michele Reed is a notable inventor based in Loveland, Ohio, who has made significant contributions to the field of biochemistry. With a total of two patents to her name, she has focused her research on methods to inhibit the conversion of certain compounds that can lead to health issues.

Latest Patents

Her latest patents include "Methods for inhibiting conversion of carnitine to trimethylamine (TMA)" and "Methods for inhibiting conversion of choline to trimethylamine (TMA)." The first patent provides a method for inhibiting the conversion of carnitine to TMA, which is crucial for lowering TMAO levels in individuals. This method involves administering compositions that contain specific compounds in effective amounts. The second patent similarly addresses the conversion of choline to TMA, offering methods to lower TMAO by inhibiting the formation of TMA from choline.

Career Highlights

Throughout her career, Jodie has worked with prominent organizations such as The Procter & Gamble Company and The Cleveland Clinic Foundation. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Stanley Leon Hazen and Jose Carlos Garcia-Garcia. Their collaborative efforts have further advanced the understanding of trimethylamine production and its implications for health.

Conclusion

Jodie Michele Reed's innovative work in inhibiting the conversion of carnitine and choline to trimethylamine showcases her dedication to improving health outcomes through scientific research. Her contributions are significant in the ongoing quest to understand and mitigate health risks associated with these compounds.